These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18466649)

  • 1. Pro/Con debate: is procalcitonin useful for guiding antibiotic decision making in critically ill patients?
    Shehabi Y; Seppelt I
    Crit Care; 2008; 12(3):211. PubMed ID: 18466649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting.
    Albrich WC; Harbarth S
    Intensive Care Med; 2015 Oct; 41(10):1739-51. PubMed ID: 26194026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients--calculated sample size: 1816 patients.
    Assink-de Jong E; de Lange DW; van Oers JA; Nijsten MW; Twisk JW; Beishuizen A
    BMC Infect Dis; 2013 Apr; 13():178. PubMed ID: 23590389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using procalcitonin-guided algorithms to improve antimicrobial therapy in ICU patients with respiratory infections and sepsis.
    Schuetz P; Raad I; Amin DN
    Curr Opin Crit Care; 2013 Oct; 19(5):453-60. PubMed ID: 23817026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
    Evid Based Child Health; 2013 Jul; 8(4):1297-371. PubMed ID: 23877944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Comparison of Procalcitonin Guidance Administer Antibiotics with Empiric Antibiotic Therapy in Critically Ill Patients Admitted in Intensive Care Unit.
    Najafi A; Khodadadian A; Sanatkar M; Shariat Moharari R; Etezadi F; Ahmadi A; Imani F; Khajavi MR
    Acta Med Iran; 2015; 53(9):562-7. PubMed ID: 26553084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procalcitonin in intensive care units: the PRORATA trial.
    Mokart D; Leone M
    Lancet; 2010 May; 375(9726):1605; author reply 1606-7. PubMed ID: 20452515
    [No Abstract]   [Full Text] [Related]  

  • 8. Procalcitonin in intensive care units: the PRORATA trial.
    Tarnow-Mordi W; Gebski V
    Lancet; 2010 May; 375(9726):1605; author reply 1606-7. PubMed ID: 20452513
    [No Abstract]   [Full Text] [Related]  

  • 9. Procalcitonin in intensive care units: the PRORATA trial.
    Gibot S
    Lancet; 2010 May; 375(9726):1605-6; author reply 1606-7. PubMed ID: 20452514
    [No Abstract]   [Full Text] [Related]  

  • 10. Procalcitonin to guide duration of antibiotic therapy in intensive care patients: some research questions.
    Kahn RE
    Crit Care; 2009; 13(4):414; author reply 414. PubMed ID: 19664199
    [No Abstract]   [Full Text] [Related]  

  • 11. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Schuetz P; Wirz Y; Sager R; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bucher HC; Bhatnagar N; Annane D; Reinhart K; Branche A; Damas P; Nijsten M; de Lange DW; Deliberato RO; Lima SS; Maravić-Stojković V; Verduri A; Cao B; Shehabi Y; Beishuizen A; Jensen JS; Corti C; Van Oers JA; Falsey AR; de Jong E; Oliveira CF; Beghe B; Briel M; Mueller B
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD007498. PubMed ID: 29025194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
    de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW
    Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.
    Bouadma L; Luyt CE; Tubach F; Cracco C; Alvarez A; Schwebel C; Schortgen F; Lasocki S; Veber B; Dehoux M; Bernard M; Pasquet B; Régnier B; Brun-Buisson C; Chastre J; Wolff M;
    Lancet; 2010 Feb; 375(9713):463-74. PubMed ID: 20097417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical biomarker procalcitonin (PCT) and its effect on antibiotic usage.
    Kappes J
    S D Med; 2010 May; 63(5):178-9. PubMed ID: 20462063
    [No Abstract]   [Full Text] [Related]  

  • 15. [Procalcitonin-based algorithm. Management of antibiotic therapy in critically ill patients].
    Hochreiter M; Schroeder S
    Anaesthesist; 2011 Jul; 60(7):661-73. PubMed ID: 21660525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daily monitoring of biomarkers of sepsis in complicated long-term ICU-patients: can it support treatment decisions?
    Iapichino G; Marzorati S; Umbrello M; Baccalini R; Barassi A; Cainarca M; Colombo Pavini F; Mantovani E; Mauri A; Moroni B; Noto A; Melzi D'Eril GV; Langer M
    Minerva Anestesiol; 2010 Oct; 76(10):814-23. PubMed ID: 20935617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibiotic treatment of surgical intensive care patients: procalcitonin to guide duration of therapy].
    Hochreiter M; Köhler T; Schweiger AM; Keck FS; Bein B; von Spiegel T; Schröder S
    Anaesthesist; 2008 Jun; 57(6):571-7. PubMed ID: 18463831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procalcitonin-guided antibiotic treatment in heart failure.
    Sandek A; Springer J; Habedank D; Brunkhorst F; Anker SD
    Lancet; 2004 May; 363(9420):1555; author reply 1555-6. PubMed ID: 15135615
    [No Abstract]   [Full Text] [Related]  

  • 19. [A Cochrane meta-analysis regarding procalcitonin is in accordance with international goals for the use of antibiotics].
    Berg PL; Lindhardt BO
    Ugeskr Laeger; 2013 Dec; 175(50):3093-6. PubMed ID: 24629531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When once is not enough--further evidence of procalcitonin-guided antibiotic stewardship.
    Harbarth S; Albrich WC; Müller B
    Crit Care; 2009; 13(4):165. PubMed ID: 19664168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.